HLB Pep Co., Ltd. (KOSDAQ:196300)
3,955.00
-180.00 (-4.35%)
At close: Jul 20, 2026
HLB Pep Market Cap
HLB Pep has a market cap or net worth of 35.35 billion as of July 21, 2026. Its market cap has decreased by -52.87% in one year.
Market Cap
35.35B
Enterprise Value
27.37B
Revenue
5.52B
Ranking
n/a
PE Ratio
n/a
Stock Price
3,955.00
ChartMarket Cap Chart
Since December 7, 2016, HLB Pep's market cap has decreased from 59.66B to 35.35B, a decrease of -40.75%. That is a compound annual growth rate of -5.29%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 20, 2026 | 37.08B | -44.27% |
| Dec 30, 2025 | 66.54B | -5.59% |
| Dec 30, 2024 | 70.48B | -19.25% |
| Dec 28, 2023 | 87.28B | 110.23% |
| Dec 29, 2022 | 41.51B | -51.73% |
| Dec 30, 2021 | 86.00B | 24.23% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 7, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Aptamer Sciences | 52.01B |
| TegoScience | 51.64B |
| Psomagen | 50.40B |
| ADBiotech | 49.10B |
| J2KBIO | 45.84B |
| Parataxis Korea | 44.13B |
| Progen | 43.51B |
| Kainos Medicine | 35.56B |